{"id":51125,"date":"2022-11-22T14:02:09","date_gmt":"2022-11-22T13:02:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/"},"modified":"2022-11-22T14:02:09","modified_gmt":"2022-11-22T13:02:09","slug":"revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/","title":{"rendered":"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference"},"content":{"rendered":"
\n

NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the 34th<\/sup> Annual Piper Sandler Healthcare Conference, taking place November 29-December 1, 2022, in New York City. Chief Executive Officer, Mark J. Foley, is scheduled to present on Tuesday, November 29, at 10:00AM ET.\n<\/p>\n

\nInterested parties can access the live audio webcast for this conference from the Events page of the Investor Relations section of the company’s website at www.revance.com<\/a>. The webcast replay will be available after the conclusion of the live presentation for approximately 90 days.\n<\/p>\n

\nAbout Revance<\/b>\n<\/p>\n

\nRevance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences. Revance\u2019s aesthetics portfolio of expertly created products and services, including DAXXIFY\u2122 (DaxibotulinumtoxinA-lanm) for injection, the RHA\u00ae Collection of dermal fillers, and OPUL\u00ae, the first-of-its-kind Relational Commerce platform for aesthetic practices, deliver a differentiated and exclusive offering for the company\u2019s elite practice partners and their consumers. Revance has also partnered with Viatris Inc. to develop a biosimilar to BOTOX\u00ae, which will compete in the existing short-acting neuromodulator marketplace. Revance\u2019s therapeutics pipeline is currently focused on muscle movement disorders including evaluating DAXXIFY\u2122 in two debilitating conditions, cervical dystonia and upper limb spasticity.\n<\/p>\n

\nRevance is headquartered in Nashville, Tennessee, with additional office locations in Newark, Pleasanton and Irvine, California. Learn more at www.Revance.com<\/a> or connect with us on LinkedIn<\/a>.\n<\/p>\n

\n\u201cRevance\u201d and the Revance logo and OPUL are registered trademarks of Revance Therapeutics, Inc.\n<\/p>\n

\nResilient Hyaluronic Acid\u00ae and RHA\u00ae are trademarks of TEOXANE SA.
\n
BOTOX\u00ae is a registered trademark of Allergan, Inc.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/b>
Revance Therapeutics, Inc.:
\n
Sara Fahy, 949-887-4476
\n
sfahy@revance.com<\/a>\n<\/p>\n

\nInvestors<\/b>
Revance Therapeutics, Inc.:
\n
Jessica Serra, 510-279-6886
\n
jessica.serra@revance.com<\/a>
or
\n
Gilmartin Group, LLC.:
\n
Laurence Watts, 619-916-7620
\n
laurence@gilmartinir.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the 34th Annual Piper Sandler Healthcare Conference, taking place November 29-December 1, 2022, in New York City. Chief Executive Officer, Mark J. Foley, is scheduled to present on Tuesday, November … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51125","6":"format-standard","7":"category-industry"},"yoast_head":"\nRevance to Participate in the 34th Annual Piper Sandler Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the 34th Annual Piper Sandler Healthcare Conference, taking place November 29-December 1, 2022, in New York City. Chief Executive Officer, Mark J. Foley, is scheduled to present on Tuesday, November ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T13:02:09+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference\",\"datePublished\":\"2022-11-22T13:02:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\\\/\"},\"wordCount\":328,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\\\/\",\"name\":\"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-11-22T13:02:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference - Pharma Trend","og_description":"NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the 34th Annual Piper Sandler Healthcare Conference, taking place November 29-December 1, 2022, in New York City. Chief Executive Officer, Mark J. Foley, is scheduled to present on Tuesday, November ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-22T13:02:09+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference","datePublished":"2022-11-22T13:02:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/"},"wordCount":328,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/","name":"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-11-22T13:02:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51125"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51125\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}